Alert detail
LCD L35984: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) — CGS
What changed
CGS J15 final LCD on thrombophilia genetic testing live 6/19/25.
Who’s affected: Clinical Laboratory billing teams · Effective: June 19, 2025
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 8 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.